2 months ago
ARGX
AnalystsAllison BratzelAllison Bratzel's Stock Forecasts
AnalystsAllison Bratzel
Sectors:
Industries:
Analyst Ranking
Top 10%
#464 out of 5064 analysts
Average Return
+31.45%
Win Rate
71%25 out of 35
Risk vs Reward
Poor
Good
Allison Bratzel's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Inozyme Pharma IncINZY | +277.36% | $1.06 | $4.00 | 2025-03-11 - 2025-07-01 | Strong Buy |
Scholar Rock Holding CorpSRRK | +121.87% | $15.00 | $33.28 | 2024-03-26 - 2025-03-25 | Strong Buy |
Ionis Pharmaceuticals IncIONS | +94.44% | $37.23 | $72.39 | 2024-11-14 - 2025-10-15 | Strong Buy |
Scholar Rock Holding CorpSRRK | +86.26% | $8.44 | $15.72 | 2023-04-03 - 2024-04-02 | Strong Buy |
Vectivbio Holding AgVECT | +77.37% | $9.50 | $16.85 | 2023-04-20 - 2023-07-07 | Strong Buy |
Allison Bratzel Analyst Color
Get additional color on Allison Bratzel's coverage of popular stocks
2 months ago
IONS
3 months ago
ABVX
4 months ago
REPL
7 months ago
AKBA
a year ago
ARGX
a year ago
SRRK
a year ago
ROIV
2 years ago
ARGX
Allison Bratzel's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | 4 | Strong Buy | $51.00 | +57.41% | Maintains | 22 days ago |
Argenx SeARGX | 14 | Strong Buy | $820.00 | +0.54% | Maintains | 2 months ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Buy | $65.00 | -10.21% | Maintains | 2 months ago |
Abivax SaABVX | 1 | Strong Buy | $112.00 | +17.14% | Maintains | 3 months ago |
Replimune Group IncREPL | 2 | Strong Buy | $22.00 | +364.14% | Maintains | 4 months ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $33.00 | +115.69% | Assumes | 5 months ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $115.00 | +244.00% | Maintains | 7 months ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $6.00 | +103.39% | Maintains | 7 months ago |
Inozyme Pharma IncINZY | 1 | Strong Buy | $23.00 | +475.00% | Maintains | 7 months ago |
Engene Holdings IncENGN | 1 | Strong Buy | $26.00 | +195.45% | Initiates Coverage On | 8 months ago |
Travere Therapeutics IncTVTX | 2 | Hold | $22.00 | -18.06% | Maintains | a year ago |
Rigel Pharmaceuticals IncRIGL | 2 | Hold | $23.00 | -18.18% | Maintains | a year ago |
Roivant Sciences LtdROIV | 2 | Strong Buy | $22.00 | N/A | Maintains | a year ago |
Humacyte IncHUMA | 2 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Solid Biosciences IncSLDB | 4 | Strong Buy | $20.00 | N/A | Upgrades | 2 years ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $20.00 | N/A | Assumes | 2 years ago |
Vectivbio Holding AgVECT | 1 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Incyte CorpINCY | 2 | Strong Buy | $100.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.